AstraZeneca requests Emergency Use Authorisation for drug to prevent Covid
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
The first clinical trial is expected to commence in early 2022 both in Europe and the US
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
The state-of-the-art facility provides a pathway from development to large-scale biologics production
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
Torrent is one of India's fastest-growing pharma majors
Cipla is a leading global pharma company
Subscribe To Our Newsletter & Stay Updated